The activated clotting time (ACT) is a test that is used primarily to monitor high doses of unfractionated (standard) heparin therapy. Heparin is a drug that inhibits blood clotting (anticoagulant) and is usually given intravenously (IV) by injection or continuous infusion. High doses of heparin may be given during procedures that require that blood be prevented from clotting, such as heart bypass surgery.
Market Analysis and Insights: Global Activated Clotting Time Testing Market
The global Activated Clotting Time Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Activated Clotting Time Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Activated Clotting Time Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Activated Clotting Time Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Activated Clotting Time Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Activated Clotting Time Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Activated Clotting Time Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Roche
Thermo Fisher Scientific
Abbott
Helena Laboratories
Sysmex
Medtronic
Instrumentation Laboratory
Diagnostica Stago
Werfen
LabCorp
Segment by Type
Optical Detection
Laser-based Detection
Mechanical Detection
Fluorescent Based Detection
Segment by Application
Hospitals
Clinical Laboratories
Ambulatory Surgical Center
Academic & Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Activated Clotting Time Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Activated Clotting Time Testing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Activated Clotting Time Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Activated Clotting Time Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Optical Detection
1.2.3 Laser-based Detection
1.2.4 Mechanical Detection
1.2.5 Fluorescent Based Detection
1.3 Market by Application
1.3.1 Global Activated Clotting Time Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Ambulatory Surgical Center
1.3.5 Academic & Research Institutes
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Activated Clotting Time Testing Market Perspective (2019-2030)
2.2 Global Activated Clotting Time Testing Growth Trends by Region
2.2.1 Activated Clotting Time Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Activated Clotting Time Testing Historic Market Size by Region (2019-2024)
2.2.3 Activated Clotting Time Testing Forecasted Market Size by Region (2025-2030)
2.3 Activated Clotting Time Testing Market Dynamics
2.3.1 Activated Clotting Time Testing Industry Trends
2.3.2 Activated Clotting Time Testing Market Drivers
2.3.3 Activated Clotting Time Testing Market Challenges
2.3.4 Activated Clotting Time Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Activated Clotting Time Testing by Players
3.1.1 Global Activated Clotting Time Testing Revenue by Players (2019-2024)
3.1.2 Global Activated Clotting Time Testing Revenue Market Share by Players (2019-2024)
3.2 Global Activated Clotting Time Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Activated Clotting Time Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Activated Clotting Time Testing Market Concentration Ratio
3.4.1 Global Activated Clotting Time Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Activated Clotting Time Testing Revenue in 2023
3.5 Global Key Players of Activated Clotting Time Testing Head office and Area Served
3.6 Global Key Players of Activated Clotting Time Testing, Product and Application
3.7 Global Key Players of Activated Clotting Time Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Activated Clotting Time Testing Breakdown Data by Type
4.1 Global Activated Clotting Time Testing Historic Market Size by Type (2019-2024)
4.2 Global Activated Clotting Time Testing Forecasted Market Size by Type (2025-2030)
5 Activated Clotting Time Testing Breakdown Data by Application
5.1 Global Activated Clotting Time Testing Historic Market Size by Application (2019-2024)
5.2 Global Activated Clotting Time Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Activated Clotting Time Testing Market Size (2019-2030)
6.2 North America Activated Clotting Time Testing Market Size by Type
6.2.1 North America Activated Clotting Time Testing Market Size by Type (2019-2024)
6.2.2 North America Activated Clotting Time Testing Market Size by Type (2025-2030)
6.2.3 North America Activated Clotting Time Testing Market Share by Type (2019-2030)
6.3 North America Activated Clotting Time Testing Market Size by Application
6.3.1 North America Activated Clotting Time Testing Market Size by Application (2019-2024)
6.3.2 North America Activated Clotting Time Testing Market Size by Application (2025-2030)
6.3.3 North America Activated Clotting Time Testing Market Share by Application (2019-2030)
6.4 North America Activated Clotting Time Testing Market Size by Country
6.4.1 North America Activated Clotting Time Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Activated Clotting Time Testing Market Size by Country (2019-2024)
6.4.3 North America Activated Clotting Time Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Activated Clotting Time Testing Market Size (2019-2030)
7.2 Europe Activated Clotting Time Testing Market Size by Type
7.2.1 Europe Activated Clotting Time Testing Market Size by Type (2019-2024)
7.2.2 Europe Activated Clotting Time Testing Market Size by Type (2025-2030)
7.2.3 Europe Activated Clotting Time Testing Market Share by Type (2019-2030)
7.3 Europe Activated Clotting Time Testing Market Size by Application
7.3.1 Europe Activated Clotting Time Testing Market Size by Application (2019-2024)
7.3.2 Europe Activated Clotting Time Testing Market Size by Application (2025-2030)
7.3.3 Europe Activated Clotting Time Testing Market Share by Application (2019-2030)
7.4 Europe Activated Clotting Time Testing Market Size by Country
7.4.1 Europe Activated Clotting Time Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Activated Clotting Time Testing Market Size by Country (2019-2024)
7.4.3 Europe Activated Clotting Time Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Activated Clotting Time Testing Market Size (2019-2030)
8.2 China Activated Clotting Time Testing Market Size by Type
8.2.1 China Activated Clotting Time Testing Market Size by Type (2019-2024)
8.2.2 China Activated Clotting Time Testing Market Size by Type (2025-2030)
8.2.3 China Activated Clotting Time Testing Market Share by Type (2019-2030)
8.3 China Activated Clotting Time Testing Market Size by Application
8.3.1 China Activated Clotting Time Testing Market Size by Application (2019-2024)
8.3.2 China Activated Clotting Time Testing Market Size by Application (2025-2030)
8.3.3 China Activated Clotting Time Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Activated Clotting Time Testing Market Size (2019-2030)
9.2 Asia Activated Clotting Time Testing Market Size by Type
9.2.1 Asia Activated Clotting Time Testing Market Size by Type (2019-2024)
9.2.2 Asia Activated Clotting Time Testing Market Size by Type (2025-2030)
9.2.3 Asia Activated Clotting Time Testing Market Share by Type (2019-2030)
9.3 Asia Activated Clotting Time Testing Market Size by Application
9.3.1 Asia Activated Clotting Time Testing Market Size by Application (2019-2024)
9.3.2 Asia Activated Clotting Time Testing Market Size by Application (2025-2030)
9.3.3 Asia Activated Clotting Time Testing Market Share by Application (2019-2030)
9.4 Asia Activated Clotting Time Testing Market Size by Region
9.4.1 Asia Activated Clotting Time Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Activated Clotting Time Testing Market Size by Region (2019-2024)
9.4.3 Asia Activated Clotting Time Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Activated Clotting Time Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Activated Clotting Time Testing Introduction
11.1.4 Roche Revenue in Activated Clotting Time Testing Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Activated Clotting Time Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Activated Clotting Time Testing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Activated Clotting Time Testing Introduction
11.3.4 Abbott Revenue in Activated Clotting Time Testing Business (2019-2024)
11.3.5 Abbott Recent Developments
11.4 Helena Laboratories
11.4.1 Helena Laboratories Company Details
11.4.2 Helena Laboratories Business Overview
11.4.3 Helena Laboratories Activated Clotting Time Testing Introduction
11.4.4 Helena Laboratories Revenue in Activated Clotting Time Testing Business (2019-2024)
11.4.5 Helena Laboratories Recent Developments
11.5 Sysmex
11.5.1 Sysmex Company Details
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Activated Clotting Time Testing Introduction
11.5.4 Sysmex Revenue in Activated Clotting Time Testing Business (2019-2024)
11.5.5 Sysmex Recent Developments
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Activated Clotting Time Testing Introduction
11.6.4 Medtronic Revenue in Activated Clotting Time Testing Business (2019-2024)
11.6.5 Medtronic Recent Developments
11.7 Instrumentation Laboratory
11.7.1 Instrumentation Laboratory Company Details
11.7.2 Instrumentation Laboratory Business Overview
11.7.3 Instrumentation Laboratory Activated Clotting Time Testing Introduction
11.7.4 Instrumentation Laboratory Revenue in Activated Clotting Time Testing Business (2019-2024)
11.7.5 Instrumentation Laboratory Recent Developments
11.8 Diagnostica Stago
11.8.1 Diagnostica Stago Company Details
11.8.2 Diagnostica Stago Business Overview
11.8.3 Diagnostica Stago Activated Clotting Time Testing Introduction
11.8.4 Diagnostica Stago Revenue in Activated Clotting Time Testing Business (2019-2024)
11.8.5 Diagnostica Stago Recent Developments
11.9 Werfen
11.9.1 Werfen Company Details
11.9.2 Werfen Business Overview
11.9.3 Werfen Activated Clotting Time Testing Introduction
11.9.4 Werfen Revenue in Activated Clotting Time Testing Business (2019-2024)
11.9.5 Werfen Recent Developments
11.10 LabCorp
11.10.1 LabCorp Company Details
11.10.2 LabCorp Business Overview
11.10.3 LabCorp Activated Clotting Time Testing Introduction
11.10.4 LabCorp Revenue in Activated Clotting Time Testing Business (2019-2024)
11.10.5 LabCorp Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Roche
Thermo Fisher Scientific
Abbott
Helena Laboratories
Sysmex
Medtronic
Instrumentation Laboratory
Diagnostica Stago
Werfen
LabCorp
听
听
*If Applicable.
